Who has invested in Biocept?

Needham Capital Partners, Chardan Capital, ROTH Capital Partners are named among the investors backing Biocept.

Biocept Funding: $97M Raised, Investors & Rounds

Biocept funding overview

Biocept has raised $97M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Biocept runs through 2020; nothing later has been disclosed. Investors on record include Needham Capital Partners, Chardan Capital, ROTH Capital Partners. 3 distinct backers are named across the disclosed rounds.

Biocept at a glance

Total raised: $97M
Latest round date: January 2020
Notable investors: Needham Capital Partners, Chardan Capital, ROTH Capital Partners

Frequently asked about Biocept funding

How much has Biocept raised?: Biocept has raised $97M in total disclosed funding across the rounds on record.
Who has invested in Biocept?: Needham Capital Partners, Chardan Capital, ROTH Capital Partners are named among the investors backing Biocept.
What was the latest Biocept funding round?: No round stage has been disclosed for Biocept.
Where is Biocept based?: No headquarters location is disclosed for Biocept.
When did Biocept last raise?: The last disclosed Biocept round closed in January 2020.

Biocept totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Biocept Funding: $97M Raised, Investors & Rounds

Biocept funding overview

Biocept at a glance

Frequently asked about Biocept funding

Companies related to Biocept (30)

Browse related funding lists (2)